Optiver Holding’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.6K Buy
195
+117
+150% +$10.7K ﹤0.01% 1551
2026
Q1
$7.51K Buy
78
+40
+105% +$4K ﹤0.01% 1298
2025
Q4
$3.7K Sell
38
-10
-21% -$858 ﹤0.01% 1592
2025
Q3
$3.42K Buy
+48
New +$3.2K ﹤0.01% 2081

Other funds holding IRMD

Optiver Holding's IRMD Position: Q2 2026 in Review

Optiver Holding increased its iRadimed (IRMD) stake by 150% in Q2 2026, buying an estimated $10.7K and bringing the position to 195 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Optiver Holding first reported a position in IRMD in Q3 2025 and has held it in 4 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Optiver Holding held 195 shares of iRadimed worth $18.6K as of Q2 2026.
  • Optiver Holding bought 117 iRadimed shares in Q2 2026, an estimated $10.7K.
  • iRadimed made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1551 holding.
  • Optiver Holding first reported a position in iRadimed in Q3 2025 and has held it in 4 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.